Read more business news at:
Trending Now
AG Brad Schimel has awarded the remainder of the first round school safety grants. Schimel yesterday announced 60 schools and districts will get the remaining $2.6 million in funding. That leaves some $48 million in funding for applicants interested in the second round of grant funding to shore up mental health initiatives in schools, among other things. Among the recipients yesterday...
WisPolitics Midday – August 17, 2018
In today's WisPolitics Midday Update: A business group's ad buy against Tony Evers is now over $2.5 million; AG Brad Schimel hands out the...
WisOpinion.com: ‘The Insiders’ assign primary winners and losers
With the primary results in the books, the WisOpinion Insiders, Chvala and Jensen, assign winners and losers in races for governor, U.S. Senate and other contests. Sponsored by Michael Best Strategies and the Wisconsin Counties Association.
Christian Schneider: Students need a civics education now more than ever
This corrosion of civic education is manifesting itself in the types of leaders Americans are choosing and in what citizens expect of those leaders once they take office.
William Barth: Truth can survive ‘fake news’; it cannot survive disinterest
Call this "fake news" if you want, but I think if independent journalism some day disappears, we, the people, can count on getting the government we will deserve.
Matt Rothschild: Trump and the road to fascism
America is not a fascist state yet. But it could get there in a hurry.
Foxconn official suggests company’s $10 billion investment will grow
Foxconn’s director of U.S. initiatives, Alan Yeung, suggests the company’s initial $10 billion investment in Racine County will grow. He said yesterday the company’s planned...
New VC funds looking to health tech for opportunities
Two of the state’s newest venture capital funds are looking for big opportunities in health care technology. The Wisconsin Technology Council recently hosted a panel...
Madison company achieves 94 percent tumor reduction in clinical trial
Cellectar Biosciences has achieved 94 percent tumor reduction in a patient taking part in a clinical trial for the company’s cancer treatment. The Madison-based pharmaceutical...
